Literature DB >> 21544814

Candidate driver genes in microsatellite-unstable colorectal cancer.

Pia Alhopuro1, Heli Sammalkorpi, Iina Niittymäki, Mia Biström, Anniina Raitila, Juha Saharinen, Kari Nousiainen, Heli J Lehtonen, Elina Heliövaara, Jani Puhakka, Sari Tuupanen, Sónia Sousa, Raquel Seruca, Ana M Ferreira, Robert M W Hofstra, Jukka-Pekka Mecklin, Heikki Järvinen, Ari Ristimäki, Torben F Orntoft, Sampsa Hautaniemi, Diego Arango, Auli Karhu, Lauri A Aaltonen.   

Abstract

Defects in the mismatch repair system lead to microsatellite instability (MSI), a feature observed in ∼ 15% of all colorectal cancers (CRCs). Microsatellite mutations that drive tumourigenesis, typically inactivation of tumour suppressors, are selected for and are frequently detected in MSI cancers. Here, we evaluated somatic mutations in microsatellite repeats of 790 genes chosen based on reduced expression in MSI CRC and existence of a coding mononucleotide repeat of 6-10 bp in length. All the repeats were initially sequenced in 30 primary MSI CRC samples and whenever frameshift mutations were identified in >20%, additional 70 samples were sequenced. To distinguish driver mutations from passengers, we similarly analyzed the occurrence of frameshift mutations in 121 intronic control repeats and utilized a statistical regression model to determine cut-off mutation frequencies for repeats of all types (A/T and C/G, 6-10 bp). Along with several know target genes, including TGFBR2, ACVR2, and MSH3, six novel candidate driver genes emerged that harbored significantly more mutations than identical control repeats. The mutation frequencies in 100 MSI CRC samples were 51% in G8 of GLYR1, 47% in T9 of ABCC5, 43% in G8 of WDTC1, 33% in A8 of ROCK1, 30% in T8 of OR51E2, and 28% in A8 of TCEB3. Immunohistochemical staining of GLYR1 revealed defective protein expression in tumors carrying biallelic mutations, supporting a loss of function hypothesis. This is a large scale, unbiased effort to identify genes that when mutated are likely to contribute to MSI CRC development.
Copyright © 2011 UICC.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21544814     DOI: 10.1002/ijc.26167

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  45 in total

1.  Optimization of a pentaplex panel for MSI analysis without control DNA in a Brazilian population: correlation with ancestry markers.

Authors:  Nathália C Campanella; Gustavo N Berardinelli; Cristovam Scapulatempo-Neto; Danilo Viana; Edenir I Palmero; Rui Pereira; Rui M Reis
Journal:  Eur J Hum Genet       Date:  2013-11-06       Impact factor: 4.246

2.  3'-UTR poly(T/U) repeat of EWSR1 is altered in microsatellite unstable colorectal cancer with nearly perfect sensitivity.

Authors:  Johanna Kondelin; Sari Tuupanen; Alexandra E Gylfe; Mervi Aavikko; Laura Renkonen-Sinisalo; Heikki Järvinen; Jan Böhm; Jukka-Pekka Mecklin; Claus L Andersen; Pia Vahteristo; Esa Pitkänen; Lauri A Aaltonen
Journal:  Fam Cancer       Date:  2015-09       Impact factor: 2.375

Review 3.  The molecular pathogenesis of colorectal cancer and its potential application to colorectal cancer screening.

Authors:  William M Grady; Sanford D Markowitz
Journal:  Dig Dis Sci       Date:  2014-12-10       Impact factor: 3.199

Review 4.  Role of Short Chain Fatty Acid Receptors in Intestinal Physiology and Pathophysiology.

Authors:  Medha Priyadarshini; Kumar U Kotlo; Pradeep K Dudeja; Brian T Layden
Journal:  Compr Physiol       Date:  2018-06-18       Impact factor: 9.090

5.  An integrated approach to identify causal network modules of complex diseases with application to colorectal cancer.

Authors:  Zhenshu Wen; Zhi-Ping Liu; Zhengrong Liu; Yan Zhang; Luonan Chen
Journal:  J Am Med Inform Assoc       Date:  2012-09-11       Impact factor: 4.497

6.  Kinase-Dependent and -Independent Roles for PTK6 in Colon Cancer.

Authors:  Priya S Mathur; Jessica J Gierut; Grace Guzman; Hui Xie; Rosa M Xicola; Xavier Llor; Michael I Chastkofsky; Ansu O Perekatt; Angela L Tyner
Journal:  Mol Cancer Res       Date:  2016-03-16       Impact factor: 5.852

7.  AAPL: Assessing Association between P-value Lists.

Authors:  Tianwei Yu; Yize Zhao; Shihao Shen
Journal:  Stat Anal Data Min       Date:  2013-04-01       Impact factor: 1.051

8.  A genome-wide view of microsatellite instability: old stories of cancer mutations revisited with new sequencing technologies.

Authors:  Tae-Min Kim; Peter J Park
Journal:  Cancer Res       Date:  2014-11-04       Impact factor: 12.701

9.  IgG Glycome in Colorectal Cancer.

Authors:  Frano Vučković; Evropi Theodoratou; Kujtim Thaçi; Maria Timofeeva; Aleksandar Vojta; Jerko Štambuk; Maja Pučić-Baković; Pauline M Rudd; Lovorka Đerek; Dražen Servis; Annika Wennerström; Susan M Farrington; Markus Perola; Yurii Aulchenko; Malcolm G Dunlop; Harry Campbell; Gordan Lauc
Journal:  Clin Cancer Res       Date:  2016-02-01       Impact factor: 12.531

10.  SF3B1 mutations are associated with alternative splicing in uveal melanoma.

Authors:  Marc-Henri Stern; Richard Marais; Simon J Furney; Malin Pedersen; David Gentien; Amaury G Dumont; Audrey Rapinat; Laurence Desjardins; Samra Turajlic; Sophie Piperno-Neumann; Pierre de la Grange; Sergio Roman-Roman
Journal:  Cancer Discov       Date:  2013-07-16       Impact factor: 39.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.